United Physicians: A Unified Voice Advocating for the Needs of Physicians by Physicians for Physicians

United Physicians, a nonprofit, is a new kind of physician organization specifically created to advance the interests of physicians and patients. United Physicians advocates as a unified physician voice for quality patient care lead solely by physician members, with every significant decision being made by the entire organization of voting members.

United Physicians is an “alliance,” not a union. Members can sign up for free on the website, submit important issues they would like to see advocated for, and vote on advancing any issue. As each issue advances through the voting process, specific goals and estimated budgets are assigned and voted on by the entire membership.

COVID-19 highlighted the need for physicians to unify around important changes in medicine that will not only impact their own lives but the lives of their patients. United Physicians was also formed to provide a platform for physicians to collectively share ideas and solutions to combat the rising tide of physician burnout and suicide. United Physicians hopes that this new platform will give physicians a louder and more strategic voice.

Most physicians believe they are excluded from discussions that impact their livelihood and how they care for patients. Hospitals and insurance boards are staffed with executives, not physicians. Professional organizations built to protect physicians such as American Medical Association (about 250,000 members) and the American College of Physicians (about 160,000 members), are governed from the top down and not solely focused on the interests of physicians.

United Physicians is a new approach, something that has not been tried before. There may not be a better time for the 800,000 physicians in the United States to unify for a seat at the decision table.

“United Physicians offers the first platform of its kind allowing the opportunity for physicians to join together to advocate on big issues impacting our profession. We need a majority of physicians to join to make this a truly unified voice for change, not only for our patients but to improve the profession we love,” said Paul Teirstein MD, Chief of Cardiology at Scripps Clinic La Jolla and one of the founding physicians of United Physicians.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”